Addition of cetuximab to first-line chemotherapy in patients with advanced non-small-cell lung cancer: a cost–utility analysis
Keyword(s):
2020 ◽
Vol 21
◽
pp. 9-16
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2006 ◽
Vol 98
(24)
◽
pp. 1786-1794
◽
Keyword(s):
2020 ◽
Vol 12
◽
pp. 175883592098036
2013 ◽
Vol 8
(10)
◽
pp. 1255-1264
◽
Keyword(s):
Keyword(s):
2009 ◽
Vol 15
(8)
◽
pp. 669-682
◽
Keyword(s):